Short-interval retreatment with stereotactic body radiotherapy (SBRT) for pediatric neuroblastoma resulting in severe myositis Journal Article


Authors: Taunk, N. K.; Kushner, B.; Ibanez, K.; Wolden, S. L.
Article Title: Short-interval retreatment with stereotactic body radiotherapy (SBRT) for pediatric neuroblastoma resulting in severe myositis
Abstract: We report a severe and not previously reported toxicity after short-interval retreatment with stereotactic body radiotherapy (SBRT) in a pediatric patient with neuroblastoma. This patient experienced Grade III radiation myositis after treatment with conventional radiation therapy followed by high-dose SBRT for persistent disease a short interval after the initial radiotherapy course. While SBRT shows outstanding rates of local control in adult disease, data in pediatric cancers are extremely limited. In this report, we discuss the rationale of SBRT in this patient's multimodality neuroblastoma treatment, management of the toxicity, and future perspectives on the use of SBRT in pediatric cancer. © 2016 Wiley Periodicals, Inc.
Keywords: neuroblastoma; stereotactic body radiotherapy; sbrt; myositis
Journal Title: Pediatric Blood and Cancer
Volume: 63
Issue: 4
ISSN: 1545-5009
Publisher: Wiley Periodicals, Inc  
Date Published: 2016-04-01
Start Page: 731
End Page: 733
Language: English
DOI: 10.1002/pbc.25863
PROVIDER: scopus
PUBMED: 26806854
PMCID: PMC5029085
DOI/URL:
Notes: Article -- Export Date: 4 April 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brian Kushner
    312 Kushner
  2. Suzanne L Wolden
    562 Wolden
  3. Neil Taunk
    31 Taunk
  4. Katarzyna   Ibanez
    18 Ibanez